Authors: THOELEN S VANDAMME P MATHEI C LEROUXROELS G DESOMBERE I SAFARY A VANDEPAPELIERE P SLAOUI M MEHEUS A

Citation: S. Thoelen et al., SAFETY AND IMMUNOGENICITY OF A HEPATITIS-B VACCINE FORMULATED WITH A NOVEL ADJUVANT SYSTEM, Vaccine, 16(7), 1998, pp. 708-714

Authors: VANHERCK K VANDAMME P THOELEN S MEHEUS A

Citation: K. Vanherck et al., LONG-TERM PERSISTENCE OF ANTI-HBS AFTER VACCINATION WITH A RECOMBINANT-DNA YEAST-DERIVED HEPATITIS-B VACCINE - 8-YEAR RESULTS, Vaccine, 16(20), 1998, pp. 1933-1935

Authors: BERTINO JS THOELEN S VANDAMME P BRYAN JP BECHERER PR FREY S HAYDEN FG MARCUS LC PARENTI DM SPERLING M CHAN ISF BROWN L NALIN D

Citation: Js. Bertino et al., A DOSE-RESPONSE STUDY OF HEPATITIS-A VACCINE IN HEALTHY-ADULTS WHO ARE GREATER-THAN-OR-EQUAL-TO-30 YEARS OLD AND WEIGH GREATER-THAN-OR-EQUAL-TO-77 KG, The Journal of infectious diseases, 178(4), 1998, pp. 1181-1184

Authors: THOELEN S VANDAMME P BEUTELS M MATHEI C MEHEUS A

Citation: S. Thoelen et al., IMMUNOGENICITY OF A COMBINED HEPATITIS-A AND HEPATITIS-B VACCINE IN HEALTHY-ADULTS, Hepatology, 23(1), 1996, pp. 254-254

Authors: VANDAMME P THOELEN S MEHEUS A SAFARY A ANDRE FE MATHEI C

Citation: P. Vandamme et al., SINGLE-DOSE INACTIVATED HEPATITIS-A VACCINE - RATIONALE AND CLINICAL-ASSESSMENT OF THE SAFETY AND IMMUNOGENICITY, Journal of medical virology, 44(4), 1994, pp. 435-441

Authors: VANDAMME P THOELEN S CRAMM M DEGROOTE K SAFARY A MEHEUS A

Citation: P. Vandamme et al., INACTIVATED HEPATITIS-A VACCINE - REACTOGENICITY, IMMUNOGENICITY, ANDLONG-TERM ANTIBODY PERSISTENCE, Journal of medical virology, 44(4), 1994, pp. 446-451